267 related articles for article (PubMed ID: 22065657)
1. Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study.
Tzoulaki I; Siontis KC; Ioannidis JP
BMJ; 2011 Nov; 343():d6829. PubMed ID: 22065657
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
Colditz GA
Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
[TBL] [Abstract][Full Text] [Related]
4. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study.
Toews I; Anglemyer A; Nyirenda JL; Alsaid D; Balduzzi S; Grummich K; Schwingshackl L; Bero L
Cochrane Database Syst Rev; 2024 Jan; 1(1):MR000034. PubMed ID: 38174786
[TBL] [Abstract][Full Text] [Related]
5. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
Anglemyer A; Horvath HT; Bero L
Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
[TBL] [Abstract][Full Text] [Related]
6. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
[TBL] [Abstract][Full Text] [Related]
7. Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.
Flowers N; Hartley L; Todkill D; Stranges S; Rees K
Cochrane Database Syst Rev; 2014; 2014(12):CD010405. PubMed ID: 25474484
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.
Li L; Li S; Deng K; Liu J; Vandvik PO; Zhao P; Zhang L; Shen J; Bala MM; Sohani ZN; Wong E; Busse JW; Ebrahim S; Malaga G; Rios LP; Wang Y; Chen Q; Guyatt GH; Sun X
BMJ; 2016 Feb; 352():i610. PubMed ID: 26888822
[TBL] [Abstract][Full Text] [Related]
9. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.
Abraha I; Cherubini A; Cozzolino F; De Florio R; Luchetta ML; Rimland JM; Folletti I; Marchesi M; Germani A; Orso M; Eusebi P; Montedori A
BMJ; 2015 May; 350():h2445. PubMed ID: 26016488
[TBL] [Abstract][Full Text] [Related]
10. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies.
Li L; Shen J; Bala MM; Busse JW; Ebrahim S; Vandvik PO; Rios LP; Malaga G; Wong E; Sohani Z; Guyatt GH; Sun X
BMJ; 2014 Apr; 348():g2366. PubMed ID: 24736555
[TBL] [Abstract][Full Text] [Related]
11. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.
Golder S; Loke YK; Bland M
PLoS Med; 2011 May; 8(5):e1001026. PubMed ID: 21559325
[TBL] [Abstract][Full Text] [Related]
12. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery.
Chung C; Bryant A; Brown PD
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011492. PubMed ID: 29987845
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.
Li X; Meng X; Timofeeva M; Tzoulaki I; Tsilidis KK; Ioannidis JP; Campbell H; Theodoratou E
BMJ; 2017 Jun; 357():j2376. PubMed ID: 28592419
[No Abstract] [Full Text] [Related]
16. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
17. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
18. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
19. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies.
Savović J; Jones H; Altman D; Harris R; Jűni P; Pildal J; Als-Nielsen B; Balk E; Gluud C; Gluud L; Ioannidis J; Schulz K; Beynon R; Welton N; Wood L; Moher D; Deeks J; Sterne J
Health Technol Assess; 2012 Sep; 16(35):1-82. PubMed ID: 22989478
[TBL] [Abstract][Full Text] [Related]
20. Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders.
Santos JAR; Christoforou A; Trieu K; McKenzie BL; Downs S; Billot L; Webster J; Li M
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD010734. PubMed ID: 30746700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]